References
- Barbieri RL. Hyperandrogenic disorders. Clin Obstet Gynecol 1990;33:640–54
- Knochenhauer ES, Azziz R. Advances in the diag-nosis and treatment of hirsute patients. Curr Opin Obstet Gynecol 1995;7:344–50
- Serafini P, Lobo RA. Increased 5-alfa reductase activity in idiopathic hirsutism. Fertil Steril 1985; 43:74–8
- Convey GS, Honour JW, Jacobs HS. Heterogeneity of the polycystic ovary syndrome; clinical, endocrine and ultrasound features in 556 patients. Clin Endocrinol 1989;30: 459–70
- Delahunt JW. Hirsutism. Drugs 1993;45:223–31
- Rittmaster RS. Medical treatment of androgen-dependent hirsutism. J Clin Endocrinol Metab 1995; 80:2559–63
- Rittmaster RS. Finasteride. N Engl J Med 1994; 330:120–5
- Castello R, Tosi F, Perrone F, et al. Outcome of long term treatment with the 5a-reductase inhibitor finasteride in the idiopathic hirsutism: clinical and hormonal effects during a 1-year course of therapy and 1-year follow up. Fertil Steril 1996;66:734–40
- Falsetti L, De Fusco D, Eleftheriou G, etal. Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary syndrome. Gynecol Endocrinol 1997;11:251–7
- Bayram F, Miiderris II, Sahin Y, et al. Finasteride treatment for one year in 35 hirsute patients. Exp Clin Endocrinol Diab 1999;107:195–7
- Hach R, Rosenfield R, Kim MH, et al. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 1981;140:815–26
- Poretsky L, Piper B. Insulin resistance, hypersecretion of LH, and a dual-defect hypothesis on the pathogenesis of polycystic ovary syndrome. Obstet Gynecol 1994;84:613–21
- Tremblay RR. Treatment of hirsutism with spironolactone. J Clin Endocrinol Metab 1986;5:363–71
- Kelqtimur F, Sahin Y. Comparison of Diane 35 and Diane 35 plus spironolactone in the treatment of hirsutism. Fertil Steril 1998;69:66–9
- Hammerstein J, Meckies J, Leo-Rossberg I. Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism. J Steroid Biochem 1975;6: 827–36
- Milderris II, Bayram F, Sahin Y, etal. The efficacy of 250-mg/day flutamide in the treatment of patients with hirsutism. Fertil Steril 1996;66:220–2
- Miiderris II, Bayram F. Clinical efficacy oflower dose flutamide 125 mg/day in the treatment of hirsutism. J Endocrinol Invest 1999;22:165–8
- Tolmo A, Petrone A, Sarnacchiaro F, etal. Finasteride in the treatment of hirsutism: new therapeutic perspectives. Fertil Steril 1996;66:61–5
- Rittmaster RS. Hirsutism. Lancet 1997;349:191–5
- Venturoli S, Marescalchi O, Colombo FM, et al. A prospective randomised trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate—estrogen regimens in the treatment of hirsutism. J Clin Endocrinol Metab 1999;84:1304–10
- Moghetti P, Castello R, Magnani CM, et al. Clinical and hormonal effects of the 5a-reductase inhibitor finasteride in idiopathic hirsutism. J Clin Endocrinol Metab 1994;79:1115–21
- Wong IL, Morris RS, Chang L, et al. A prospective randomized trial comparing finasteride to spirono-lactone in the treatment of hirsute women. J Clin Endocrinol Metab 1995;80:233–8
- Falsetti L, Gambera A, Legrenzi L, et al. Comparison of finasteride and flutamide in the treatment of hirsutism. Eur J Endocrinol 1999;141:361–7
- Sahin Y, Bayram F, Kelqtimur F, et al. Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism. J Endocrinol Invest 1998;21:348–52
- Sahin Y, Dilber S, Kelqtimur F. Comparison of Diane-35 and Diane-35 plus finasteride in the treat-ment of hirsutism. Fertil Steril 2001;75: 496–500